Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Developing an Analytic Tool Using a Participatory Research Approach to Examine Gender Differences in the Living Kidney Donation Process. [PDF]
Gouin-Bonenfant M +10 more
europepmc +1 more source
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Examining the Intersectional and Structural Issues of Routine Healthcare Utilization and Access Inequities for LGB People with Chronic Diseases. [PDF]
Cao S +5 more
europepmc +1 more source
Success by design: A holistic analysis of design principles for depression apps. [PDF]
Werth O +7 more
europepmc +1 more source
An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. [PDF]
Halliday DM +6 more
europepmc +1 more source
Expanding Insurance Coverage for Pediatric Upper Extremity Recreational Prosthetic Devices. [PDF]
Lazar S +3 more
europepmc +1 more source
Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity. [PDF]
Chen LP +8 more
europepmc +1 more source

